Alison R. Walker

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali et al. · Journal of the National Comprehensive Cancer Network · 2016 · 293 citations

Hematological Malignancy, Oncology, Diagnostic Classification +14

Targeted Delivery of <i>microRNA-29b</i> by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia

Xiaomeng Huang, Sebastian Schwind, Bo Yu et al. · Clinical Cancer Research · 2013 · 189 citations · Full text

Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia

Areej El‐Jawahri, Thomas W. LeBlanc, Alison R. Kavanaugh et al. · JAMA Oncology · 2020 · 167 citations · Full text

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia

Alice S. Mims, Alison R. Walker, Xiaomeng Huang et al. · Leukemia · 2012 · 59 citations · Full text

Hematological Malignancy, Novel Epigenetic-targeting Approach, Anti-leukemic Activity +9

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Gail J. Roboz, Sumithra J. Mandrekar, Pinkal Desai et al. · Blood Advances · 2018 · 55 citations · Full text